You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Novel single-agent immunotherapies
705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020170026
Dec 202036014
Jan 202164017
Feb 202163012
Mar 202164015
Apr 202190022
May 202130033
Jun 20210016
Jul 20210033
Aug 20211031
Sep 20210021
Oct 202186032
Nov 2021184051
Dec 2021126024
Jan 2022106020
Feb 2022104017
Mar 2022174018
Apr 202278011
May 20226809
Jun 2022102019
Jul 20227809
Aug 2022132022
Sep 2022110019
Oct 202276010
Nov 2022108012
Dec 202274015
Jan 202392019
Feb 2023102016
Mar 2023110020
Apr 202366021
May 202390019
Jun 2023118023
Jul 202366016
Aug 202392017
Sep 202384012
Oct 2023102019
Nov 2023134024
Dec 202310604
Jan 20244204
Feb 20246406
Mar 202480010
Apr 2024110012
May 20248806
Jun 202495015
Jul 2024116017
Aug 2024160027
Sep 2024108018
Oct 2024200042
Nov 2024126031
Dec 2024104011
Jan 2025178032
Feb 202516020
Mar 20250021
Apr 20250017
May 20250020
Jun 20250014
Total477301061